Galapagos N.V.
Research Galapagos N.V. (0JXZ) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- Ticker0JXZ
- ExchangeLSE
- CountryBelgium
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
About Galapagos N.V.
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma;
Frequently asked questions
What does Galapagos N.V. do?
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus;